Shares of Medovex Corp. (NASDAQ:MDVX) saw an uptick in trading volume on Wednesday following insider buying activity. 777,806 shares were traded during mid-day trading, an increase of 526% from the previous session’s volume of 124,319 shares.The stock last traded at $0.95 and had previously closed at $0.90.

Specifically, Director Steve Gorlin acquired 200,000 shares of the business’s stock in a transaction on Wednesday, August 16th. The stock was purchased at an average price of $0.90 per share, for a total transaction of $180,000.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In the last quarter, insiders acquired 295,989 shares of company stock valued at $268,750. Corporate insiders own 25.10% of the company’s stock.

The firm’s market capitalization is $18.03 million. The stock’s 50-day moving average is $0.91 and its 200 day moving average is $1.14.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at

Medovex Corp. Company Profile

MedoveX Corporation, through its subsidiaries, focuses on developing medical devices primarily in the United States and Europe. It offers DenerveX device, a disposable single-use kit for the treatment of various medical applications, including pain relief. The company serves healthcare providers, physicians, and third-party payors.

Receive News & Ratings for Medovex Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medovex Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.